These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15946698)

  • 1. Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood--brain barrier: comparison of mouse and human brain microvessels.
    Banks WA; Kumar VB; Franko MW; Bess JW; Arthur LO
    Life Sci; 2005 Sep; 77(19):2361-8. PubMed ID: 15946698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated.
    Banks WA; Robinson SM; Wolf KM; Bess JW; Arthur LO
    Neuroscience; 2004; 128(1):143-53. PubMed ID: 15450361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide.
    Banks WA; Kastin AJ; Brennan JM; Vallance KL
    Exp Neurol; 1999 Mar; 156(1):165-71. PubMed ID: 10192787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis.
    Banks WA; Kastin AJ; Akerstrom V
    Life Sci; 1997; 61(9):PL119-25. PubMed ID: 9284088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
    Price TO; Ercal N; Nakaoke R; Banks WA
    Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis.
    Banks WA; Freed EO; Wolf KM; Robinson SM; Franko M; Kumar VB
    J Virol; 2001 May; 75(10):4681-91. PubMed ID: 11312339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFP-lentiviral vectors targeting for neuroAIDS.
    Lu Y
    Methods Mol Biol; 2009; 515():177-97. PubMed ID: 19378133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer.
    Nakaoke R; Ryerse JS; Niwa M; Banks WA
    Exp Neurol; 2005 May; 193(1):101-9. PubMed ID: 15817268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lectin-mediated brain uptake of HIV-1 GP120.
    Banks WA; Kastin AJ
    J Neurosci Res; 1998 Nov; 54(4):522-9. PubMed ID: 9822162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor.
    Banks WA; Akerstrom V; Kastin AJ
    J Cell Sci; 1998 Feb; 111 ( Pt 4)():533-40. PubMed ID: 9443901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes.
    Louboutin JP; Reyes BA; Agrawal L; Maxwell CR; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2010 May; 38(2):313-25. PubMed ID: 20219678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism.
    Annunziata P
    J Neurol; 2003 Aug; 250(8):901-6. PubMed ID: 12928906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein.
    Ronaldson PT; Bendayan R
    Mol Pharmacol; 2006 Sep; 70(3):1087-98. PubMed ID: 16790532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of wheatgerm agglutinin and aging on the regional brain uptake of HIV-1GP120.
    Banks WA; Ibrahimi F; Farr SA; Flood JF; Morley JE
    Life Sci; 1999; 65(1):81-9. PubMed ID: 10403496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission routes of HIV-1 gp120 from brain to lymphoid tissues.
    Cashion MF; Banks WA; Bost KL; Kastin AJ
    Brain Res; 1999 Mar; 822(1-2):26-33. PubMed ID: 10082880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.